Scaled up to commercial production of low-cost mechanical ventilator with device for sanitizing patient air

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • Known Financial Commitments (USD)

    $360,348.32
  • Funder

    MinScience - Colombia
  • Principal Investigator

    N/A

  • Research Location

    Colombia
  • Lead Research Institution

    UNIVERSIDAD DE ANTIOQUIA
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Supportive care, processes of care and management

  • Special Interest Tags

    N/A

  • Study Type

    Non-Clinical

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Not Applicable

  • Vulnerable Population

    Not applicable

  • Occupations of Interest

    Not applicable

Abstract

The advance of the pandemic caused by SARS-CoV-2, has generated the collapse of health systems in many parts of the planet. This occurs when the number of patients requiring medical attention exceeds the installed capacity of the hospital units. One of the requirements of COVID-19 patients is the use of mechanical ventilators. In this project, in a University-Company-State alliance, it is intended to optimize a prototype of an existing mechanical fan developed by the company ION HEAT SAS, to achieve the serial production of a device that is comparable to existing professional mechanical fans. today on the market. On the other hand, it is also intended to include within the mechanical ventilator, an air sanitization system, based on nanotechnology, which allows medical care centers not to become sources of spread of the virus. With the execution of this project, there will be a production line for mechanical ventilators that will help supply the demand for these equipment at the national level, and in this way prevent the health system and ICUs from collapsing. In addition, it is intended to implement an air sanitization device within the ventilator that allows the retention and deactivation of pathogens, including SARS-CoV-2, to prevent care units from becoming sites of spread.